NEW YORK, April 23 (GenomeWeb News) - Bruker BioSciences hopes to raise $12.6 million in net proceeds from a public offering of 3 million shares of its common stock, the company said today.
The offering coincides with the sale of 12 million shares by four stockholders related to CEO Frank Laukien to the public, which is expected to generate $50.5 million in net proceeds.
The stock will be priced at $4.50 per share.
Bruker said it plans to use the proceeds for general corporate purposes, potential acquisitions, and possibly for the repayment of debt.